International comparison of assessments of pharmaceutical innovation
Author:
- 1 May 2012
- journal article
- research article
- Published by Elsevier in Health Policy
- Vol. 105 (2-3) , 221-225
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Evaluation of Oncology Drugs at the European Medicines Agency and US Food and Drug Administration: When Differences Have an Impact on Clinical PracticeJournal of Clinical Oncology, 2011
- Disappointing biotechBMJ, 2005
- Therapeutic innovation in the European Union: analysis of the drugs approved by the EMEA between 1995 and 2003British Journal of Clinical Pharmacology, 2005
- Judging the therapeutic value of drugs: A comparison between La revue Prescrire and Information från Läkemedelsverket, the bulletin of the Swedish Medical Products AgencyInternational Journal of Risk & Safety in Medicine, 2004
- Efficacy, safety, and cost of new anticancer drugsBMJ, 2002
- The Measurement of Observer Agreement for Categorical DataBiometrics, 1977